Genomma Lab (Mexico) Buy Hold or Sell Recommendation
| LABB Stock | MXN 25.78 0.27 1.06% |
Assuming the 90 days trading horizon and your highly speculative risk level, our recommendation regarding Genomma Lab Internacional is 'Strong Buy'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Genomma Lab Internacional given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Genomma Lab Internacional, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Genomma Lab Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Genomma and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Genomma Lab Internacional. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Genomma |
Execute Genomma Lab Buy or Sell Advice
The Genomma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Genomma Lab Internacional. Macroaxis does not own or have any residual interests in Genomma Lab Internacional or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Genomma Lab's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Genomma Lab Trading Alerts and Improvement Suggestions
| About 29.0% of the company outstanding shares are owned by corporate insiders |
Genomma Lab Returns Distribution Density
The distribution of Genomma Lab's historical returns is an attempt to chart the uncertainty of Genomma Lab's future price movements. The chart of the probability distribution of Genomma Lab daily returns describes the distribution of returns around its average expected value. We use Genomma Lab Internacional price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Genomma Lab returns is essential to provide solid investment advice for Genomma Lab.
| Mean Return | 0.33 | Value At Risk | -3.3 | Potential Upside | 3.39 | Standard Deviation | 2.02 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Genomma Lab historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Genomma Lab Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Genomma Lab or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Genomma Lab's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Genomma stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.32 | |
β | Beta against Dow Jones | 0.31 | |
σ | Overall volatility | 1.99 | |
Ir | Information ratio | 0.15 |
Genomma Lab Volatility Alert
Genomma Lab Internacional has relatively low volatility with skewness of 0.31 and kurtosis of 1.02. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Genomma Lab's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Genomma Lab's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Genomma Lab Fundamentals Vs Peers
Comparing Genomma Lab's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Genomma Lab's direct or indirect competition across all of the common fundamentals between Genomma Lab and the related equities. This way, we can detect undervalued stocks with similar characteristics as Genomma Lab or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Genomma Lab's fundamental indicators could also be used in its relative valuation, which is a method of valuing Genomma Lab by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Genomma Lab to competition |
| Fundamentals | Genomma Lab | Peer Average |
| Return On Equity | 0.13 | -0.31 |
| Return On Asset | 0.0921 | -0.14 |
| Profit Margin | 0.08 % | (1.27) % |
| Operating Margin | 0.20 % | (5.51) % |
| Current Valuation | 20.43 B | 16.62 B |
| Shares Outstanding | 1 B | 571.82 M |
| Shares Owned By Insiders | 29.00 % | 10.09 % |
| Shares Owned By Institutions | 29.10 % | 39.21 % |
| Price To Earning | 13.61 X | 28.72 X |
| Price To Book | 1.51 X | 9.51 X |
| Price To Sales | 1.05 X | 11.42 X |
| Revenue | 15.49 B | 9.43 B |
| Gross Profit | 9.56 B | 27.38 B |
| EBITDA | 2.84 B | 3.9 B |
| Net Income | 1.31 B | 570.98 M |
| Cash And Equivalents | 1.41 B | 2.7 B |
| Cash Per Share | 1.40 X | 5.01 X |
| Total Debt | 3.83 B | 5.32 B |
| Debt To Equity | 0.61 % | 48.70 % |
| Current Ratio | 1.75 X | 2.16 X |
| Book Value Per Share | 10.98 X | 1.93 K |
| Cash Flow From Operations | 1.47 B | 971.22 M |
| Earnings Per Share | 1.30 X | 3.12 X |
| Price To Earnings To Growth | (5.24) X | 4.89 X |
| Target Price | 22.41 | |
| Number Of Employees | 2.3 K | 18.84 K |
| Beta | 0.53 | -0.15 |
| Market Capitalization | 18.09 B | 19.03 B |
| Total Asset | 21.54 B | 29.47 B |
| Z Score | 2.4 | 8.72 |
| Annual Yield | 0.04 % | |
| Net Asset | 21.54 B | |
| Last Dividend Paid | 0.38 |
Genomma Lab Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Genomma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Genomma Lab Buy or Sell Advice
When is the right time to buy or sell Genomma Lab Internacional? Buying financial instruments such as Genomma Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Genomma Lab in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Market ETFs Thematic Idea Now
Broad Market ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Market ETFs theme has 62 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Market ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Genomma Stock Analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.